2025 second_quarter Filing
Q2Lobbying Activities
Tax issues related to the pharmaceutical industry. H.R. 1, "One Big Beautiful Bill Act".
Issues related to patent protections.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health. Pharmacy benefit manager reform proposals.